Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05169957
Title Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

melanoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Rogel Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field